Pharmaceutical Revenue vs R&D Spending (2019 to 2025)
The above chart is Pharmaceutical Revenue vs R&D Spending (2019 to 2025) by Global – ($500B+).
Data source: Evaluate Pharma World Preview (2025)
Market Dynamics
The pharmaceutical industry continues to invest heavily in R&D to address unmet medical needs and replenish pipelines as blockbuster drugs lose exclusivity. Revenue growth has been driven by specialty drugs, biologics, and expansion in emerging markets. R&D intensity remains high as the industry pursues complex therapeutic areas including oncology and rare diseases.
A plan for every need
Forecast+
Lorem ipsum dolor sit amet, consecte tur adipiscing elit sedis nisi ut aliqui si liguine
More charts from the same report
View AllPowering the world's best teams.
From next-gen startups to established enterprises.
Contact Us
Get in Touch
See our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence